ePRO and eCOA: Digital solutions driving clinical trials engagement
Recruiting enough participants and keeping them engaged through lengthy clinical trials is increasingly challenging. In fact, more than 80% of…
Recruiting enough participants and keeping them engaged through lengthy clinical trials is increasingly challenging. In fact, more than 80% of…
Obesity is a chronic disease defined by excessive fat accumulation, typically diagnosed by a body mass index (BMI) of ≥30,…
A recent survey for GlobalData’s “State of the Biopharmaceutical Industry 2025” report, conducted at the end of 2024, found drug…
Global immunization programs have successfully eradicated or controlled many infectious diseases throughout history. However, challenges like antimicrobial resistance, climate change,…
The global cell and gene therapy (CGT) market is expanding at a rapid rate, and will be worth $76bn by…
Cell and gene therapy (C>) represents a major advance in medical treatments by directly targeting the root causes of diseases…
The obesity therapeutics market has gone from a standing start to the story of the year in biopharmaceuticals - and…
With the MS Trust estimating that more than 2.9 million people worldwide have multiple sclerosis (MS), new therapies are urgently…
The latest EU clinical trial regulations must be carefully understood. The Clinical Trial Regulation (CTR) was introduced in the EU…
May 2025 - London & Boston - Perceptive eClinical unveils ClinPhone Pro, a next-generation RTSM platform. Built on over 30…